Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban-Reference-Cited by-同舟云学术

Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban

Published:2011-12 Issue:8 Volume:22 Page:637-641
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Harenberg Job,Marx Svetlana,Krämer Roland,Giese Christina,Weiss Christel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference17 articles.

1. New oral anticoagulants in development.;Weitz;Thromb Haemost,2010

2. Rivaroxaban: a new oral factor Xa inhibitor.;Perzborn;Arterioscler Thromb Vasc Biol,2010

3. EINSTEIN InvestigatorsOral rivaroxaban for symptomatic venous thromboembolism.;Bauersachs;N Engl J Med,2010

4. Determination of rivaroxaban - a novel, oral, direct factor Xa inhibitor - in human plasma by high-performance liquid chromatography-tandem mass spectrometry.;Rohde;J Chromatogr B Analyt Technol Biomed Life Sci,2008

5. An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma.;Samama;Thromb Haemost,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits;Open Life Sciences;2022-01-01

2. Determination of the cut-off prothrombin time to estimate plasma rivaroxaban overdose status;Journal of Thrombosis and Thrombolysis;2019-09-10

3. The rivaroxaban-adjusted normalized ratio: use of the prothrombin time to monitor the therapeutic effect of rivaroxaban;British Journal of Biomedical Science;2019-06-17

4. Consenso sulla diagnostica di laboratorio per i pazienti in trattamento con farmaci anticoagulanti ad azione diretta. Sottoscritto dalla Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET), dalla Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA), dalla Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC) e dalla Società Italiana di Patologia Clinica e Medicina di Laboratorio (SIPMeL);La Rivista Italiana della Medicina di Laboratorio;2019-05

5. The effect of warfarin, heparin, and modern directly acting oral anticoagulants (dabigatran etexilate, rivaroxaban, apixaban) on the level of coagulation factors: V, VII, VIII, IX, XII, WF;HERALD of North-Western State Medical University named after I.I. Mechnikov;2019-04-25